Literature DB >> 11069186

Crystal structure of fibroblast growth factor receptor ectodomain bound to ligand and heparin.

L Pellegrini1, D F Burke, F von Delft, B Mulloy, T L Blundell.   

Abstract

Fibroblast growth factors (FGFs) are a large family of structurally related proteins with a wide range of physiological and pathological activities. Signal transduction requires association of FGF with its receptor tyrosine kinase (FGFR) and heparan sulphate proteoglycan in a specific complex on the cell surface. Direct involvement of the heparan sulphate glycosaminoglycan polysaccharide in the molecular association between FGF and its receptor is essential for biological activity. Although crystal structures of binary complexes of FGF-heparin and FGF-FGFR have been described, the molecular architecture of the FGF signalling complex has not been elucidated. Here we report the crystal structure of the FGFR2 ectodomain in a dimeric form that is induced by simultaneous binding to FGF1 and a heparin decasaccharide. The complex is assembled around a central heparin molecule linking two FGF1 ligands into a dimer that bridges between two receptor chains. The asymmetric heparin binding involves contacts with both FGF1 molecules but only one receptor chain. The structure of the FGF1-FGFR2-heparin ternary complex provides a structural basis for the essential role of heparan sulphate in FGF signalling.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11069186     DOI: 10.1038/35039551

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  207 in total

Review 1.  Molecular diversity of heparan sulfate.

Authors:  J D Esko; U Lindahl
Journal:  J Clin Invest       Date:  2001-07       Impact factor: 14.808

2.  Crystal structure of the OpcA integral membrane adhesin from Neisseria meningitidis.

Authors:  Stephen M Prince; Mark Achtman; Jeremy P Derrick
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-12       Impact factor: 11.205

Review 3.  Heparan sulfate proteoglycans: heavy hitters in the angiogenesis arena.

Authors:  R V Iozzo; J D San Antonio
Journal:  J Clin Invest       Date:  2001-08       Impact factor: 14.808

Review 4.  Heparan sulfate: growth control with a restricted sequence menu.

Authors:  J T Gallagher
Journal:  J Clin Invest       Date:  2001-08       Impact factor: 14.808

5.  Role of constraint in catalysis and high-affinity binding by proteins.

Authors:  Donald G Vanselow
Journal:  Biophys J       Date:  2002-05       Impact factor: 4.033

6.  Adaptation of tick-borne encephalitis virus to BHK-21 cells results in the formation of multiple heparan sulfate binding sites in the envelope protein and attenuation in vivo.

Authors:  C W Mandl; H Kroschewski; S L Allison; R Kofler; H Holzmann; T Meixner; F X Heinz
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

7.  Accommodation of a highly symmetric core within a symmetric protein superfold.

Authors:  Stephen R Brych; Jaewon Kim; Timothy M Logan; Michael Blaber
Journal:  Protein Sci       Date:  2003-12       Impact factor: 6.725

8.  Probing the role of proline -135 on the structure, stability, and cell proliferation activity of human acidic fibroblast growth factor.

Authors:  Julie Eberle Davis; Arwa Alghanmi; Ravi Kumar Gundampati; Srinivas Jayanthi; Ellen Fields; Monica Armstrong; Vanessa Weidling; Varun Shah; Shilpi Agrawal; Bhanu Prasanth Koppolu; David A Zaharoff; Thallapuranam Krishnaswamy Suresh Kumar
Journal:  Arch Biochem Biophys       Date:  2018-07-19       Impact factor: 4.013

9.  Gas-Phase Analysis of the Complex of Fibroblast GrowthFactor 1 with Heparan Sulfate: A Traveling Wave Ion Mobility Spectrometry (TWIMS) and Molecular Modeling Study.

Authors:  Yuejie Zhao; Arunima Singh; Yongmei Xu; Chengli Zong; Fuming Zhang; Geert-Jan Boons; Jian Liu; Robert J Linhardt; Robert J Woods; I Jonathan Amster
Journal:  J Am Soc Mass Spectrom       Date:  2016-09-23       Impact factor: 3.109

10.  Synthesis of heparin-like oligosaccharides on polymer supports.

Authors:  Rafael Ojeda; Olimpia Terentí; José-Luis de Paz; Manuel Martín-Lomas
Journal:  Glycoconj J       Date:  2004       Impact factor: 2.916

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.